NCT02418962View on ClinicalTrials.gov

Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

February 29, 2016

Conditions
MalariaPlasmodium Falciparum
Interventions
BIOLOGICAL

PfSPZ Vaccine

Aseptic, purified, metabolically active, non-replicating (live, radiation attenuated) cryopreserved Plasmodium falciparum sporozoites vaccine

OTHER

Normal Saline

0.9% Sodium chloride solution for injection

Trial Locations (1)

Unknown

La Paz Medical Center, Malabo

Sponsors

Collaborators (1)

Marathon Oil Corporation
All Listed Sponsors
collaborator

Ifakara Health Institute

OTHER

collaborator

Swiss Tropical & Public Health Institute

OTHER

collaborator

Government of Equatorial Guinea

OTHER_GOV

collaborator

Hospital Universitario La Paz

OTHER

collaborator

Marathon Oil Corporation

INDUSTRY

collaborator

Noble Oil Services

INDUSTRY

lead

Sanaria Inc.

INDUSTRY

NCT02418962 - Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults | Biotech Hunter | Biotech Hunter